Amphastar Pharma Revenue, Profits - AMPH Annual Income Statement

Add to My Stocks
$15.77 $0.33 (2.05%) AMPH stock closing price Jun 22, 2018 (Closing)

AMPH stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Amphastar Pharma stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement for AMPH which shows a YOY revenue decline of -5.87% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The Amphastar Pharma profit and loss statement for 2017 shows a net profit of $4.5M. Profits for last year was $10.53M. Apart from this an investor should also check Amphastar Pharma assets and Amphastar Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Amphastar Pharma Revenues or Net Sales
240.17M255.16M251.51M210.46M229.68M204.32M118.35M
Cost Of Goods Sold (COGS)149.38M150.97M174.17M159.2M142.72M114.02M90.25M
Amphastar Pharma Gross Profit
90.79M104.18M77.34M51.25M86.95M90.3M28.1M
Research & Development Expense43.41M41.19M37.06M28.42M33.01M31.16M31.04M
Selling General & Admin Expense48.27M47.29M47.18M40.81M36.44M33.74M30.6M
Income Before Depreciation Depletion Amortization-0.89M15.69M-6.89M-17.98M17.48M25.39M-33.54M
Depreciation Depletion Amortization-------
Non Operating Income3.34M--2.47M--1.26M2.24M
Interest Expense-1.02M-----
Amphastar Pharma Pretax Income
1.62M14.94M-10.36M-18.14M17.22M25.87M-31.88M
Provision for Income Taxes-2.88M4.41M-7.57M-7.44M5.36M7.78M-39.63M
MinorityInterest-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations4.5M10.53M-2.78M-10.69M11.86M18.09M7.75M
Extraordinary Items & Discontinued Operations-------
Amphastar Pharma Profit/ Loss (Net Income)
4.5M10.53M-2.78M-10.69M11.86M18.09M7.75M
Average Shares used to compute Diluted EPS48.37M47.5M44.96M41.96M38.88M38.94M-
Average Shares used to compute Basic EPS46.11M45.38M44.96M41.96M38.71M38.58M-
Income Before Nonrecurring Items18.2M10.53M-1.97M-9.75M11.86M18.09M-
Income from Nonrecurring Items-13.69M--0.81M-0.95M---
Amphastar Pharma Earnings Per Share Basic Net
0.100.23-0.06-0.250.310.47-
Amphastar Pharma Earnings Per Share Diluted Net
0.090.22-0.06-0.250.310.46-
EPS Diluted Before Nonrecurring Items0.380.22-0.06-0.230.310.46-
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Amphastar Pharma stock analysis involves checking at least a few of the important things like:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that AMPH stock has a topline or revenue of $240.17M for 2017 as per this Amphastar Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $4.5M for AMPH stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The AMPH financials along with Amphastar Pharma historical stock prices provide a lot of details about the firm.

Amphastar Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
3.03
Dividend Yield
0%